BR9911609A - Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos - Google Patents

Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos

Info

Publication number
BR9911609A
BR9911609A BR9911609-0A BR9911609A BR9911609A BR 9911609 A BR9911609 A BR 9911609A BR 9911609 A BR9911609 A BR 9911609A BR 9911609 A BR9911609 A BR 9911609A
Authority
BR
Brazil
Prior art keywords
antigens
genes
antibodies
moraxella catarrhalis
catarrhalis proteins
Prior art date
Application number
BR9911609-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Carlota Vinals Y De Bassols
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811945.6A external-priority patent/GB9811945D0/en
Priority claimed from GBGB9905304.3A external-priority patent/GB9905304D0/en
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of BR9911609A publication Critical patent/BR9911609A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9911609-0A 1998-06-03 1999-05-31 Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos BR9911609A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811945.6A GB9811945D0 (en) 1998-06-03 1998-06-03 Novel compounds
GBGB9905304.3A GB9905304D0 (en) 1999-03-08 1999-03-08 Novel compounds
PCT/EP1999/003822 WO1999063093A2 (en) 1998-06-03 1999-05-31 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses

Publications (1)

Publication Number Publication Date
BR9911609A true BR9911609A (pt) 2001-02-06

Family

ID=26313784

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911609-0A BR9911609A (pt) 1998-06-03 1999-05-31 Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos

Country Status (22)

Country Link
US (3) US6803043B1 (cg-RX-API-DMAC7.html)
EP (1) EP1082435B1 (cg-RX-API-DMAC7.html)
JP (1) JP4503177B2 (cg-RX-API-DMAC7.html)
KR (3) KR100830282B1 (cg-RX-API-DMAC7.html)
CN (1) CN1311820B (cg-RX-API-DMAC7.html)
AT (1) ATE341628T1 (cg-RX-API-DMAC7.html)
AU (1) AU738896B2 (cg-RX-API-DMAC7.html)
BR (1) BR9911609A (cg-RX-API-DMAC7.html)
CA (1) CA2331196A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105820T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296086B6 (cg-RX-API-DMAC7.html)
DE (1) DE69933444T2 (cg-RX-API-DMAC7.html)
DK (1) DK1082435T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274627T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0102235A3 (cg-RX-API-DMAC7.html)
IL (2) IL139951A0 (cg-RX-API-DMAC7.html)
NO (1) NO327201B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ508617A (cg-RX-API-DMAC7.html)
PL (1) PL198031B1 (cg-RX-API-DMAC7.html)
PT (1) PT1082435E (cg-RX-API-DMAC7.html)
TR (1) TR200003608T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999063093A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20030157522A1 (en) * 2001-11-09 2003-08-21 Alain Boudreault Methods and reagents for peptide-BIR interaction screens
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BE1006377A3 (fr) 1992-11-24 1994-08-09 Raffinerie Tirlemontoise Sa Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires.
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics

Also Published As

Publication number Publication date
US20040265331A1 (en) 2004-12-30
US6803043B1 (en) 2004-10-12
CA2331196A1 (en) 1999-12-09
PL198031B1 (pl) 2008-05-30
NO20006112L (no) 2001-02-02
NO20006112D0 (no) 2000-12-01
ATE341628T1 (de) 2006-10-15
KR20070089890A (ko) 2007-09-03
AU4373299A (en) 1999-12-20
IL139951A (en) 2008-08-07
DE69933444T2 (de) 2007-03-29
IL139951A0 (en) 2002-02-10
AU738896B2 (en) 2001-09-27
PT1082435E (pt) 2007-01-31
WO1999063093A2 (en) 1999-12-09
KR100830282B1 (ko) 2008-05-16
WO1999063093A3 (en) 2000-03-02
TR200003608T2 (tr) 2001-04-20
HK1037209A1 (en) 2002-02-01
KR100911277B1 (ko) 2009-08-11
EP1082435A2 (en) 2001-03-14
NZ508617A (en) 2003-08-29
HUP0102235A1 (hu) 2001-10-28
EP1082435B1 (en) 2006-10-04
US7641910B2 (en) 2010-01-05
US20100143412A1 (en) 2010-06-10
ES2274627T3 (es) 2007-05-16
CY1105820T1 (el) 2011-02-02
CZ296086B6 (cs) 2006-01-11
KR20060129108A (ko) 2006-12-14
HUP0102235A3 (en) 2004-10-28
CN1311820A (zh) 2001-09-05
CZ20004510A3 (cs) 2001-07-11
KR20010052552A (ko) 2001-06-25
PL345193A1 (en) 2001-12-03
DE69933444D1 (de) 2006-11-16
NO327201B1 (no) 2009-05-11
CN1311820B (zh) 2011-11-16
JP4503177B2 (ja) 2010-07-14
JP2002517199A (ja) 2002-06-18
DK1082435T3 (da) 2007-02-05

Similar Documents

Publication Publication Date Title
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DE69728897D1 (de) Saeugetierchemokine
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
BR9911773A (pt) Compostos de moraxella catarrhalis
BR9914492A (pt) Polipeptìdos basb034 de moraxella catarrhalis e usos dos mesmos
DK1082435T3 (da) Proteiner og gener fra Moraxella catarrhalis, antigener, antistoffer og anvendelser
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
HK1047943A1 (zh) 黏膜炎莫拉氏菌basb114抗原及其用途
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
ATE399205T1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL.: C12N 15/31, C12N 15/62, C07K 14/21, C07K 16/12, A61K 39/02, A61K 39/40, G01N 33/50.

Ipc: C07K 14/195 (2006.01), C07K 16/12 (2006.01), C12N

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements